High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score

被引:0
|
作者
Alexander G. L. Bodelier
Daisy Jonkers
Tim van den Heuvel
Evelien de Boer
Wim Hameeteman
Ad A. M. Masclee
Marie J. Pierik
机构
[1] Maastricht University Medical Center,Division of Gastroenterology
[2] Amphia Hospital Breda,Hepatology
来源
关键词
Calprotectin; Indefinite; Disease activity; Biomarkers; Combination;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:465 / 472
页数:7
相关论文
共 50 条
  • [21] ASSESSING DISEASE SEVERITY IN PEDIATRIC IBD PATIENTS USING FECAL CALPROTECTIN AND MACHINE LEARNING
    Zachos, Mary
    Hart, Lara
    Belaghi, Reza
    Barrowman, Nick
    Benchimol, Eric I.
    Carroll, Matthew
    Crowley, Eileen
    debruyn, Jennifer C.
    Deslandres, Colette
    El-Matary, Wael
    Griffiths, Anne M.
    Jacobson, Kevan
    Huynh, Hien Q.
    Lawrence, Sally
    Ricciuto, Amanda
    Walters, Thomas D.
    Wine, Eytan
    Jantchou, Prevost
    Otley, Anthony
    Critch, Jeffrey
    Mack, David R.
    Sherlock, Mary
    GASTROENTEROLOGY, 2024, 166 (05) : S1161 - S1161
  • [22] Utilization of fecal calprotectin in monitoring disease activity and predicting relapse in IBD pregnant patients
    Rottenstreich, Amihai
    Mishael, Tali
    Grisaru-Granovsky, Sorina
    Koslowsky, Benjamin
    Goldin, Eran
    Shitrit, Ariella Bar-Gil
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S429 - S429
  • [23] Usability of a home-based test for the measurement of fecal calprotectin in asymptomatic IBD patients
    Bello, Caroline
    Roseth, Arne
    Guardiola, Jordi
    Reenaers, Catherine
    Ruiz-Cerulla, Alexandra
    Van Kemseke, Catherine
    Arajol, Claudia
    Reinhard, Christian
    Seidel, Laurence
    Louis, Edouard
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (09) : 991 - 996
  • [24] In IBD Outpatients Knowledge of Fecal Calprotectin and Infliximab Trough Levels Significantly Alters Clinical Decision Making
    Huang, Vivian
    Kroeker, Karen I.
    Wang, Haili
    Prosser, Connie
    Carol, Shalapay
    Dhami, Neil
    Fedorak, Darryl K.
    Fedorak, Richard N.
    GASTROENTEROLOGY, 2014, 146 (05) : S241 - S242
  • [25] The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis
    Onal, Ibrahim Koral
    Beyazit, Yavuz
    Sener, Burcin
    Savuk, Burak
    Etik, Digdem Ozer
    Sayilir, Abdurrahim
    Oztas, Erkin
    Torun, Serkan
    Ozin, Yasemin Ozderin
    Demirel, Bilge Tunc
    Ulker, Aysel
    Dagli, Ulku
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2012, 23 (05): : 509 - 514
  • [26] Fecal calprotectin levels in colorectal neoplasia in a high risk group.
    Kronborg, O
    Ugstad, M
    Fuglerud, P
    Hardcastle, J
    Scholefield, JH
    Vellacott, K
    Moshakis, V
    Reynolds, JR
    GASTROENTEROLOGY, 1998, 114 (04) : A629 - A629
  • [27] Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study
    Michael Manz
    Emanuel Burri
    Claude Rothen
    Nuschin Tchanguizi
    Christian Niederberger
    Livio Rossi
    Christoph Beglinger
    Frank Serge Lehmann
    BMC Gastroenterology, 12
  • [28] Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study
    Manz, Michael
    Burri, Emanuel
    Rothen, Claude
    Tchanguizi, Nuschin
    Niederberger, Christian
    Rossi, Livio
    Beglinger, Christoph
    Lehmann, Frank Serge
    BMC GASTROENTEROLOGY, 2012, 12
  • [29] ARE LOWER LEVELS OF FECAL CALPROTECTIN REASSURING IN CROHN'S DISEASE PATIENTS?
    Monteiro, Sara
    de Castro, Francisca Dias
    Leite, Silvia
    Moreira, Maria Joao
    Cotter, Jose
    GASTROENTEROLOGY, 2018, 154 (06) : S391 - S391
  • [30] Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations
    Nakov, Radislav
    Sarafov, Stayko
    Nakov, Ventsislav
    Gospodinova, Mariana
    Ianiro, Gianluca
    Todorov, Tihomir
    Todorova, Albena
    Tournev, Ivailo
    MEDICINE, 2020, 99 (11) : E19509